Investigational Nasal Spray Modestly Reduces OSA Severity
Researchers have discovered that a bedtime nasal spray has the potential to reduce the severity of OSA and next-day blood pressure.
Researchers have discovered that a bedtime nasal spray has the potential to reduce the severity of OSA and next-day blood pressure.
ResMed is updating its guides for all CPAP masks with magnets to inform users about potential magnetic interference when magnets are near certain implants and medical devices in the body.
Health Care Originals, a maker of cardiopulmonary wearable systems, acquired Dawn Health’s virtual sleep care platform to accelerate the deployment of its Nightingale virtual care to benefit Americans with asthma or COPD.
Exor NV, a Netherlands-based diversified holding company, has bought a 15% stake in Royal Philips, with an option to increase it to 20%.
A study involving over 600,000 participants revealed a significantly elevated risk of respiratory infection among individuals diagnosed with insomnia.
Multiple measures of sleep patterns and sleep efficiency are associated with lifetime diagnoses of mental illness, according to a new study that used wrist accelerometer data to track sleep.